SCHEMBL5904751

SCHEMBL5904751

Cc1cc(OC(C)(C)C(=O)O)ccc1OCC(C)c1cn(-c2ccc(C(F)(F)F)cc2)nc1C

nearest known ligand 0.46

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 20/20 0.46
PPARA Q07869 14/20 0.46
PPARG P37231 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5904911 0.89 PPARA (0.42) PPARDPPARAPPARG
SCHEMBL5904883 0.87 PPARD (0.49) PPARDPPARAPPARG
SCHEMBL5904593 0.87 PPARD (0.59) PPARDPPARA
SCHEMBL5904598 0.87 PPARD (0.59) PPARDPPARA
SCHEMBL5904752 0.87 PPARD (0.59) PPARDPPARA
SCHEMBL5904727 0.85 PPARA (0.41) PPARDPPARAPPARG
SCHEMBL5904797 0.85 PPARA (0.41) PPARDPPARAPPARG
SCHEMBL5904800 0.84 PPARD (0.49) PPARDPPARAPPARG
SCHEMBL5904746 0.84 PPARD (0.49) PPARDPPARAPPARG
SCHEMBL5904675 0.84 PPARD (0.43) PPARDPPARAPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060241157-A1 Heterocyclic ppar modulators ELI LILLY AND COMPANY 2006-10-26 US disclosed
EP-1585733-A1 HETEROCYCLIC PPAR MODULATORS ELI LILLY AND COMPANY (US) 2005-10-19 EP disclosed
WO-2004063166-A1 HETEROCYCLIC PPAR MODULATORS ELI LILLY AND COMPANY (US) 2004-07-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060241157-A1 Heterocyclic ppar modulators PPARA, PPARG, PPARD PPARD 3/4885PPARA 1/4885PPARG 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.